Truist Lowers Price Target on IRhythm Technologies to $134 From $145, Maintains Buy Rating
IRhythm Technologies Analyst Ratings
Morgan Stanley Cuts Price Target on IRhythm Technologies to $130 From $135, Keeps Overweight Rating
IRhythm Technologies Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Globus Medical (GMED), Irhythm Technologies (IRTC)
Citi Upgrades Edwards, Tandem; Cuts Nevro, Establishment Labs
Truist Financial Releases a Buy Rating on Irhythm Technologies (IRTC)
IRhythm Technologies Analyst Ratings
Canaccord Genuity Maintains Buy on IRhythm Technologies, Lowers Price Target to $122
Oppenheimer Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)
IRhythm Technologies Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Irhythm Technologies (IRTC), Zura Bio (ZURA)
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)
Analysts' Top Healthcare Picks: Avidity Biosciences (RNA), Irhythm Technologies (IRTC)
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Tarsus Pharmaceuticals (TARS) and Springworks Therapeutics (SWTX)
IRhythm Technologies Analyst Ratings
Critical Insights From IRhythm Technologies Analyst Ratings: What You Need To Know
Analysts Conflicted on These Healthcare Names: C4 Therapeutics (CCCC), Eli Lilly & Co (LLY) and Irhythm Technologies (IRTC)
Analysts Are Bullish on Top Healthcare Stocks: Veracyte (VCYT), Irhythm Technologies (IRTC)
IRhythm Technologies Analyst Ratings